Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis Patients”

Showing 20 of 0 results

Not applicableStudy completedNCT03236870
What this trial is testing

Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

Who this might be right for
Psoriasis
AbbVie 181
Not applicableUnknownNCT06370156
What this trial is testing

Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients

Who this might be right for
Plaque Psoriasis
Egymedicalpedia 100
Not applicableEnded earlyNCT01522742
What this trial is testing

Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study

Who this might be right for
Psoriasis
Massachusetts General Hospital 29
Not applicableNot Yet RecruitingNCT07391423
What this trial is testing

Assessing Psoriasis Treatment Outcomes

Who this might be right for
Psoriasis
Wake Forest University Health Sciences 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT07623486
What this trial is testing

Trial of HSK44459 Cream for the Management Plaque Psoriasis

Who this might be right for
Psoriasis
Haisco Pharmaceutical Group Co., Ltd. 180
Not applicableStudy completedNCT04074070
What this trial is testing

Prevalence of Sonographic Abnormalities of Joints and Entheses in Psoriasis Patients With or Without Musculoskeletal Complains

Who this might be right for
Psoriasis
Assistance Publique - Hôpitaux de Paris 25
Testing effectiveness (Phase 2)Study completedNCT01855880
What this trial is testing

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbGenomics B.V Taiwan Branch 54
Testing effectiveness (Phase 2)Study completedNCT01072383
What this trial is testing

Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
Biotest 49
Post-approval studies (Phase 4)Study completedNCT00249808
What this trial is testing

Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies

Who this might be right for
Psoriasis
Merck KGaA, Darmstadt, Germany 1,266
Testing effectiveness (Phase 2)Study completedNCT00625326
What this trial is testing

Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Deltanoid Pharmaceuticals 321
Early research (Phase 1)Study completedNCT03718884
What this trial is testing

Mirikizumab in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 29
Testing effectiveness (Phase 2)Study completedNCT00778700
What this trial is testing

A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Incyte Corporation 199
Large-scale testing (Phase 3)Study completedNCT03073200
What this trial is testing

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 201
Not applicableStudy completedNCT00550030
What this trial is testing

Etanercept Plus UVB-311nm Phototherapy in Psoriasis

Who this might be right for
Psoriasis
Medical University of Graz 6
Not applicableNot Yet RecruitingNCT07190391
What this trial is testing

Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis

Who this might be right for
Psoriasis
Daewoong Pharmaceutical Co. LTD. 425
Testing effectiveness (Phase 2)Study completedNCT01018134
What this trial is testing

Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 151
Not applicableStudy completedNCT02912221
What this trial is testing

Stepping Up For Inflammatory Arthritis

Who this might be right for
Arthritis, PsoriaticArthritis, Rheumatoid
University of Pennsylvania 71
Testing effectiveness (Phase 2)Study completedNCT01991197
What this trial is testing

Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.

Who this might be right for
PsoriasisType 2 Diabetes Mellitus
University College Dublin 20
Not applicableEnded earlyNCT03823924
What this trial is testing

Changes in Body Composition Under Ustekinumab in PsA

Who this might be right for
Psoriatic Arthritis
University Hospital, Lille 3
Post-approval studies (Phase 4)Study completedNCT03151551
What this trial is testing

Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Eli Lilly and Company 566
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation